DEA Waives Telemedicine and Other Rules for Controlled Substances

Published date15 April 2020
Subject MatterTelemedicine,Waivers,Prescription Drugs,DEA,Controlled Substances,Telehealth,Prescribing Authority,Coronavirus/COVID-19,Public Health Emergency
AuthorMichael Dowell
Law FirmHinshaw & Culbertson - Health Care

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT